• 1
    Dhabhar FS, McEwen BS. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci U S A 1999; 96: 105964.
  • 2
    Padgett DA, Glaser R. How stress influences the immune response. Trends Immunol 2003; 24: 4448.
  • 3
    Wilder RL. Neuroimmunoendocrinology of the rheumatic diseases: past, present, and future. Ann N Y Acad Sci 2002; 966: 139.
  • 4
    Elenkov IJ, Chrousos GP. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002; 966: 290303.
  • 5
    Dhabhar FS, McEwen BS. Bidirectional effects of stress and glucocorticoid hormones on immune function: possible explanations for paradoxical observations. In: AderR, FeltenDL, CohenN, editors. Psychoneuroimmunology. San Diego: Academic Press; 2001. p. 30138.
  • 6
    Sternberg EM. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol 2001; 169: 42935.
  • 7
    Del Rey A, Besedovsky HO. The cytokine-HPA axis circuit contributes to prevent or moderate autoimmune processes. Z Rheumatol 2000; 59 Suppl 2: II315.
  • 8
    Harbuz MS, Windle RJ, Jessop DS, Renshaw D, Ingram CD, Lightman SL. Differential effects of psychological and immunological challenge on the hypothalamo-pituitary-adrenal axis function in adjuvant-induced arthritis. Ann N Y Acad Sci 1999; 876: 4352.
  • 9
    Wick G, Sgonc R, Lechner O. Neuroendocrine-immune disturbances in animal models with spontaneous autoimmune diseases. Ann N Y Acad Sci 1998; 840: 5918.
  • 10
    Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 135162.
  • 11
    Masi AT, Aldag JC, Chatterton RT. Neuroendocrine immune perturbations in rheumatoid arthritis: causes, consequences, or confounders in the disease process? J Rheumatol 2003; 30: 23025.
  • 12
    Herrmann M, Scholmerich J, Straub RH. Stress and rheumatic diseases. Rheum Dis Clin North Am 2000; 26: 8.127.
  • 13
    Walker JG, Littlejohn GO, McMurray NE, Cutolo M. Stress system response and rheumatoid arthritis: a multilevel approach. Rheumatology (Oxford) 1999; 38: 10507.
  • 14
    Henoch MJ, Batson JW, Baum J. Psychosocial factors in juvenile rheumatoid arthritis. Arthritis Rheum 1978; 21: 22933.
  • 15
    Meyerowitz S, Jacox RF, Hess DW. Monozygotic twins discordant for rheumatoid arthritis: a genetic, clinical and psychological study of 8 sets. Arthritis Rheum 1968; 11: 121.
  • 16
    Naliboff BD, Benton D, Solomon GF, Morley JE, Fahey JL, Bloom ET, et al. Immunological changes in young and old adults during brief laboratory stress. Psychosom Med 1991; 53: 12132.
  • 17
    Feigenbaum SL, Masi AT, Kaplan SB. Prognosis in rheumatoid arthritis: a longitudinal study of newly diagnosed younger adult patients. Am J Med 1979; 66: 37784.
  • 18
    Dekkers JC, Geenen R, Evers AW, Kraaimaat FW, Bijlsma JW, Godaert GL. Biopsychosocial mediators and moderators of stress: health relationships in patients with recently diagnosed rheumatoid arthritis. Arthritis Rheum 2001; 45: 30716.
  • 19
    Dhabhar FS, Miller AH, McEwen BS, Spencer RL. Effects of stress on immune cell distribution: dynamics and hormonal mechanisms. J Immunol 1995; 154: 551127.
  • 20
    Kelley KW, Greenfield RE, Evermann JF, Parish SM, Perryman LE. Delayed-type hypersensitivity, contact sensitivity, and phytohemagglutinin skin-test responses of heat- and cold-stressed calves. Am J Vet Res 1982; 43: 7759.
  • 21
    Carr DJ, Woolley TW, Blalock JE. Phentolamine but not propranolol blocks the immunopotentiating effect of cold stress on antigen-specific IgM production in mice orally immunized with sheep red blood cells. Brain Behav Immun 1992; 6: 5063.
  • 22
    Edwards EA, Dean LM. Effects of crowding of mice on humoral antibody formation and protection to lethal antigenic challenge. Psychosom Med 1977; 39: 1924.
  • 23
    Zalcman S, Anisman H. Acute and chronic stressor effects on the antibody response to sheep red blood cells. Pharmacol Biochem Behav 1993; 46: 44552.
  • 24
    Millan S, Gonzalez-Quijano MI, Giordano M, Soto L, Martin AI, Lopez-Calderon A. Short and long restraint differentially affect humoral and cellular immune functions. Life Sci 1996; 59: 143142.
  • 25
    Glaser R, Robles TF, Sheridan J, Malarkey WB, Kiecolt-Glaser JK. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch Gen Psychiatry 2003; 60: 100914.
  • 26
    Rogers MP, Trentham DE, Dynesius-Trentham R, Daffner K, Reich P. Exacerbation of collagen arthritis by noise stress. J Rheumatol 1983; 10: 6514.
  • 27
    Strausbaugh HJ, Dallman MF, Levine JD. Repeated, but not acute, stress suppresses inflammatory plasma extravasation. Proc Natl Acad Sci U S A 1999; 96: 1462934.
  • 28
    Chover-Gonzalez AJ, Jessop DS, Tejedor-Real P, Gibert-Rahola J, Harbuz MS. Onset and severity of inflammation in rats exposed to the learned helplessness paradigm. Rheumatology (Oxford) 2000; 39: 76471.
  • 29
    Sternberg EM, Young WS, Bernardini R, Calogero AE, Chrousos GP, Gold PW, et al. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci U S A 1989; 86: 47715.
  • 30
    Dhabhar FS, McEwen BS, Spencer RL. Adaptation to prolonged or repeated stress: comparison between rat strains showing intrinsic differences in reactivity to acute stress. Neuroendocrinology 1997; 65: 3608.
  • 31
    Munck A, Guyre PM. Glucocorticoid physiology, pharmacology and stress. Adv Exp Med Biol 1986; 196: 8196.
  • 32
    Buttgereit F, Straub RH, Wehling M, Burmester GR. Glucocorticoids in the treatment of rheumatic diseases: an update on mechanisms of action. Arthritis Rheum 2004; 50: 340817.
  • 33
    Barber AE, Coyle SM, Marano MA, Fischer E, Calvano SE, Fong Y, et al. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 1993; 150: 19992006.
  • 34
    Madden KS. Catecholamines, sympathetic nerves, and immunity. In: AderR, FeltenDL, CohenN, editors. Psychoneuroimmunology. San Diego: Academic Press; 2001. p. 197216.
  • 35
    Spengler RN, Chensue SW, Giacherio DA, Blenk N, Kunkel SL. Endogenous norepinephrine regulates tumor necrosis factor-α production from macrophages in vitro. J Immunol 1994; 152: 302431.
  • 36
    Straub RH. Tables of molecular and functional neuroendocrine immune interactions. Eching (Germany): Biozol; 2000.
  • 37
    Kavelaars A, van de Pol M, Zijlstra J, Heijnen CJ. β2-adrenergic activation enhances interleukin-8 production by human monocytes. J Neuroimmunol 1997; 77: 2116.
  • 38
    Straub RH, Mayer M, Kreutz M, Leeb S, Scholmerich J, Falk W. Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J Leukoc Biol 2000; 67: 5538.
  • 39
    Kohm AP, Sanders VM. Norepinephrine: a messenger from the brain to the immune system. Immunol Today 2000; 21: 53942.
  • 40
    Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 27419.
  • 41
    Levine JD, Dardick SJ, Roizen MF, Helms C, Basbaum AI. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 1986; 6: 34239.
  • 42
    Harle P, Pongratz G, Straub RH. The sympathetic nervous system stimulates collagen-induced arthritis (CIA) in the induction phase and inhibits CIA in the late effector phase in DBA-1 mice [abstract]. Arthritis Rheum 2003; 48: S350.
  • 43
    Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, Wells J, Kanik KS, et al. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab 1997; 82: 127983.
  • 44
    Cutolo M, Foppiani L, Prete C, Ballarino P, Sulli A, Villaggio B, et al. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 1999; 26: 2828.
  • 45
    Straub RH, Pongratz G, Scholmerich J, Kees F, Schaible TF, Antoni C, et al. Long-term anti–tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion. Arthritis Rheum 2003; 48: 150412.
  • 46
    Neeck G, Federlin K, Graef V, Rusch D, Schmidt KL. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J Rheumatol 1990; 17: 249.
  • 47
    Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 1992; 326: 22630.
  • 48
    Gudbjornsson B, Skogseid B, Oberg K, Wide L, Hallgren R. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis: effect of glucocorticoids. J Rheumatol 1996; 23: 596602.
  • 49
    Gutierrez MA, Garcia ME, Rodriguez JA, Mardonez G, Jacobelli S, Rivero S. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation. J Rheumatol 1999; 26: 27781.
  • 50
    Harbuz MS, Jessop DS. Is there a defect in cortisol production in rheumatoid arthritis? Rheumatology (Oxford) 1999; 38: 298302.
  • 51
    Dekkers JC, Geenen R, Godaert GL, Glaudemans KA, Lafeber FP, van Doornen LJ, et al. Experimentally challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis. J Rheumatol 2001; 28: 1496504.
  • 52
    Pool AJ, Whipp BJ, Skasick AJ, Alavi A, Bland JM, Axford JS. Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics. Rheumatology (Oxford) 2004; 43: 438.
  • 53
    Harbuz MS, Korendowych E, Jessop DS, Crown AL, Lightman SL, Kirwan JR. Hypothalamo-pituitary-adrenal axis dysregulation in patients with rheumatoid arthritis after the dexamethasone/corticotrophin releasing factor test. J Endocrinol 2003; 178: 5560.
  • 54
    Straub RH, Kittner JM, Heijnen C, Schedlowski M, Schmidt RE, Jacobs R. Infusion of epinephrine decreases serum levels of cortisol and 17-hydroxyprogesterone in patients with rheumatoid arthritis. J Rheumatol 2002; 29: 165964.
  • 55
    Baerwald C, Graefe C, von Wichert P, Krause A. Decreased density of β-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatoid arthritis. J Rheumatol 1992; 19: 20410.
  • 56
    Heijnen CJ, Rouppe van der Voort C, Wulffraat N, van der Net J, Kuis W, Kavelaars A. Functional α1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J Neuroimmunol 1996; 71: 2236.
  • 57
    Miller LE, Justen HP, Scholmerich J, Straub RH. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 2000; 14: 2097107.
  • 58
    Lorton D, Lubahn C, Bellinger DL. Potential use of drugs that target neural-immune pathways in the treatment of rheumatoid arthritis and other autoimmune diseases. Curr Drug Targets Inflamm Allergy 2003; 2: 130.
  • 59
    Leden I, Eriksson A, Lilja B, Sturfelt G, Sundkvist G. Autonomic nerve function in rheumatoid arthritis of varying severity. Scand J Rheumatol 1983; 12: 16670.
  • 60
    Kuis W, de Jong-de Vos van Steenwijk C, Sinnema G, Kavelaars A, Prakken B, Helders PM, et al. The autonomic nervous system and the immune system in juvenile rheumatoid arthritis. Brain Behav Immun 1996; 10: 38798.
  • 61
    Perry F, Heller PH, Kamiya J, Levine JD. Altered autonomic function in patients with arthritis or with chronic myofascial pain. Pain 1989; 39: 7784.
  • 62
    Dekkers JC. Psychophysiological responsiveness in recently diagnosed patients with rheumatoid arthritis [thesis]. Dordrecht: Drukkerij Dekkers; 2000.
  • 63
    Geenen R, Godaert GL, Jacobs JW, Peters ML, Bijlsma JW. Diminished autonomic nervous system responsiveness in rheumatoid arthritis of recent onset. J Rheumatol 1996; 23: 25864.
  • 64
    Zautra AJ, Hoffman J, Potter P, Matt KS, Yocum D, Castro L. Examination of changes in interpersonal stress as a factor in disease exacerbations among women with rheumatoid arthritis. Ann Behav Med 1997; 19: 27986.
  • 65
    Zautra AJ, Hoffman JM, Matt KS, Yocum D, Potter PT, Castro WL, et al. An examination of individual differences in the relationship between interpersonal stress and disease activity among women with rheumatoid arthritis. Arthritis Care Res 1998; 11: 2719.
  • 66
    Roupe van der Voort C, Heijnen CJ, Wulffraat N, Kuis W, Kavelaars A. Stress induces increases in IL-6 production by leucocytes of patients with the chronic inflammatory disease juvenile rheumatoid arthritis: a putative role for α(1)-adrenergic receptors. J Neuroimmunol 2000; 110: 2239.
  • 67
    Hirano D, Nagashima M, Ogawa R, Yoshino S. Serum levels of interleukin 6 and stress related substances indicate mental stress condition in patients with rheumatoid arthritis. J Rheumatol 2001; 28: 4905.
  • 68
    Kittner JM, Jacobs R, Pawlak CR, Heijnen CJ, Schedlowski M, Schmidt RE. Adrenaline-induced immunological changes are altered in patients with rheumatoid arthritis. Rheumatology (Oxford) 2002; 41: 10319.
  • 69
    Kirwan JR, and The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995; 333: 1426.
  • 70
    Van Everdingen AA, Jacobs JW, Siewertsz van Reesema DR, Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 2002; 136: 112.
  • 71
    Rhee SH, Parker JC, Smarr KL, Petroski GF, Johnson JC, Hewett JE, et al. Stress management in rheumatoid arthritis: what is the underlying mechanism? Arthritis Care Res 2000; 13: 43542.